Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4727958
[patent_doc_number] => 20080207502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Anti-Angiogenic Peptides and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/665176
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14902
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665176
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665176 | Anti-Angiogenic Peptides and Methods of Use Thereof | Oct 13, 2005 | Abandoned |
Array
(
[id] => 5733464
[patent_doc_number] => 20060258581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Methods and composition for derepressions of IAP-inhibited caspase'
[patent_app_type] => utility
[patent_app_number] => 11/251617
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 126
[patent_figures_cnt] => 126
[patent_no_of_words] => 40812
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251617
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251617 | Methods and composition for derepressions of IAP-inhibited caspase | Oct 13, 2005 | Abandoned |
Array
(
[id] => 5866025
[patent_doc_number] => 20060100156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Cell nucleus-entering compositions'
[patent_app_type] => utility
[patent_app_number] => 11/240636
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9849
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100156.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240636
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240636 | Cell nucleus-entering compositions | Oct 2, 2005 | Abandoned |
Array
(
[id] => 471776
[patent_doc_number] => 07229638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-12
[patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons'
[patent_app_type] => utility
[patent_app_number] => 11/241443
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6275
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/229/07229638.pdf
[firstpage_image] =>[orig_patent_app_number] => 11241443
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/241443 | Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons | Sep 29, 2005 | Issued |
Array
(
[id] => 5710963
[patent_doc_number] => 20060052308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Transglutaminase inhibitors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/213173
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16685
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052308.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213173 | Transglutaminase inhibitors and methods of use thereof | Aug 25, 2005 | Issued |
Array
(
[id] => 5153959
[patent_doc_number] => 20070036842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Non-woven scaffold for tissue engineering'
[patent_app_type] => utility
[patent_app_number] => 11/204655
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5179
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036842.pdf
[firstpage_image] =>[orig_patent_app_number] => 11204655
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/204655 | Non-woven scaffold for tissue engineering | Aug 14, 2005 | Abandoned |
Array
(
[id] => 5153853
[patent_doc_number] => 20070036736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Hollow silica particles, compositions comprising them, and methods for making same'
[patent_app_type] => utility
[patent_app_number] => 11/200591
[patent_app_country] => US
[patent_app_date] => 2005-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6770
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036736.pdf
[firstpage_image] =>[orig_patent_app_number] => 11200591
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/200591 | Hollow silica particles, compositions comprising them, and methods for making same | Aug 9, 2005 | Issued |
Array
(
[id] => 4834132
[patent_doc_number] => 20080132679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Peptide Capable Of Binding To Insulin-Binding Protein And Adsorbent'
[patent_app_type] => utility
[patent_app_number] => 11/573834
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7324
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573834
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573834 | Peptide capable of binding to insulin-binding protein and adsorbent | Aug 8, 2005 | Issued |
Array
(
[id] => 173994
[patent_doc_number] => 07659373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Erythropoietin with high specific activity'
[patent_app_type] => utility
[patent_app_number] => 11/201006
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 12756
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659373.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201006 | Erythropoietin with high specific activity | Aug 8, 2005 | Issued |
Array
(
[id] => 5620006
[patent_doc_number] => 20060189540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Peptides for diagnostic and therapeutic methods for celiac sprue'
[patent_app_type] => utility
[patent_app_number] => 11/198068
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23803
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198068
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198068 | Peptides for diagnostic and therapeutic methods for celiac sprue | Aug 3, 2005 | Issued |
Array
(
[id] => 7247552
[patent_doc_number] => 20050272125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Method for making acylated polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/191574
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6481
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272125.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191574
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191574 | Method for making acylated polypeptides | Jul 27, 2005 | Issued |
Array
(
[id] => 6600229
[patent_doc_number] => 20100098656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications'
[patent_app_type] => utility
[patent_app_number] => 11/658803
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7138
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098656.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658803 | Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications | Jul 24, 2005 | Abandoned |
Array
(
[id] => 895701
[patent_doc_number] => 07342093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins'
[patent_app_type] => utility
[patent_app_number] => 11/187230
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 56
[patent_no_of_words] => 23549
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/342/07342093.pdf
[firstpage_image] =>[orig_patent_app_number] => 11187230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/187230 | Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins | Jul 21, 2005 | Issued |
Array
(
[id] => 5585951
[patent_doc_number] => 20090105153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Gonadotropin Releasing Hormone Antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/085496
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8451
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085496
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085496 | Gonadotropin releasing hormone antagonists | Jul 17, 2005 | Issued |
Array
(
[id] => 5113535
[patent_doc_number] => 20070197451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Carbohydrate conjugates to prevent abuse of controlled substances'
[patent_app_type] => utility
[patent_app_number] => 11/179801
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5278
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197451.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179801
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179801 | Carbohydrate conjugates to prevent abuse of controlled substances | Jul 12, 2005 | Issued |
Array
(
[id] => 5075718
[patent_doc_number] => 20070015693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Cyclosporin compositions'
[patent_app_type] => utility
[patent_app_number] => 11/181509
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 768113
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181509 | Cyclosporin compositions | Jul 12, 2005 | Abandoned |
Array
(
[id] => 7046081
[patent_doc_number] => 20050250676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Method of activating insulin receptor substrate-2 to stimulate insulin production'
[patent_app_type] => utility
[patent_app_number] => 11/179972
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11048
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179972
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179972 | Method of activating insulin receptor substrate-2 to stimulate insulin production | Jul 10, 2005 | Abandoned |
Array
(
[id] => 4571229
[patent_doc_number] => 07858679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Polymeric compositions and related methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/179218
[patent_app_country] => US
[patent_app_date] => 2005-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 47
[patent_no_of_words] => 31121
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179218
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179218 | Polymeric compositions and related methods of use | Jul 10, 2005 | Issued |
Array
(
[id] => 6187723
[patent_doc_number] => 20110171184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)'
[patent_app_type] => utility
[patent_app_number] => 11/632024
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18031
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632024 | Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) | Jul 6, 2005 | Abandoned |
Array
(
[id] => 5814805
[patent_doc_number] => 20060084607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Purified amphiphilic peptide compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/176781
[patent_app_country] => US
[patent_app_date] => 2005-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11493
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084607.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176781
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176781 | Purified amphiphilic peptide compositions and uses thereof | Jul 5, 2005 | Abandoned |